Open AccessImpact of clinical features on the efficacy of osimertinib treatment in epidermal growth factor receptor mutant non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors due to T790M mutation
Author(s) -
Liam Ck,
Mau Ern Poh,
Yong-Sheng Liam
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.08.117
Subject(s) - osimertinib , t790m , medicine , epidermal growth factor receptor , lung cancer , mutant , tyrosine kinase , cancer research , acquired resistance , tyrosine kinase inhibitor , receptor , oncology , cancer , gefitinib , erlotinib , biology , gene , biochemistry